ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.918,50
-0,36%
S&P 500
5.722,26
-0,19%
Dow Jones
41.914,75
-0,70%
Euro vs US Dollar
1,11423
0,09%
Bitcoin
63.360,75
0,36%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. INmune Bio Inc (INMB)

  7. INmune Bio Inc (INMB) News

INMB

INmune Bio (INMB)

INmune Bio Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:INMB
DatumZeitQuelleÜberschriftSymbolFirma
17/09/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
17/09/202402h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMBINmune Bio Inc
16/09/202416h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
16/09/202416h11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:INMBINmune Bio Inc
03/09/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
09/08/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
09/08/202422h00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:INMBINmune Bio Inc
08/08/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:INMBINmune Bio Inc
02/08/202422h01Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:INMBINmune Bio Inc
02/08/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
01/08/202422h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INMBINmune Bio Inc
30/07/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
19/07/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
13/06/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
12/06/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMBINmune Bio Inc
30/05/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
30/05/202414h00GlobeNewswire Inc.INmune Bio Inc. to Join Russell 3000® IndexNASDAQ:INMBINmune Bio Inc
29/05/202422h05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:INMBINmune Bio Inc
23/05/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
16/05/202422h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMBINmune Bio Inc
16/05/202422h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMBINmune Bio Inc
16/05/202422h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMBINmune Bio Inc
16/05/202422h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMBINmune Bio Inc
16/05/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMBINmune Bio Inc
16/05/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
09/05/202422h05GlobeNewswire Inc.INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business UpdateNASDAQ:INMBINmune Bio Inc
07/05/202414h00GlobeNewswire Inc.INmune Bio Inc. to Report First Quarter 2024 Financial Results and Provide a Corporate Update on Thursday, May 9NASDAQ:INMBINmune Bio Inc
30/04/202414h00GlobeNewswire Inc.INmune Bio Inc. Provides Update on Two Patients from the Phase 1b Alzheimer’s Disease Trial who Continue to Receive XPro™ Under Compassionate Use for Over Three YearsNASDAQ:INMBINmune Bio Inc
29/04/202414h00GlobeNewswire Inc.INmune Bio Inc. Completes First Cohort and Initiates Second Cohort of Phase 1/2 Study of INKmune™ Natural Killer Cell Therapy in Patients with Metastatic Castration-Resistant Prostate CancerNASDAQ:INMBINmune Bio Inc
25/04/202415h00GlobeNewswire Inc.INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:INMBINmune Bio Inc
 Showing the most relevant articles for your search:NASDAQ:INMB

Kürzlich von Ihnen besucht

LVCN
ABBCETH
ABBC Coin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten